Blocking Growth: How Anti-VEGF Therapy Is Transforming Retinal Disease Management
The Choroidal Neovascularization Market is experiencing transformative growth as anti-VEGF therapy continues to revolutionize the management of retinal diseases. According to market reports, the global Choroidal Neovascularization Market was valued at USD 1.92 billion in 2024 and is projected to reach USD 3.89 billion by 2035, exhibiting a CAGR of 6.64%. This steady growth reflects...
